跳至主要内容
临床试验/2024-518135-10-00
2024-518135-10-00招募中3 期

A randomized, placebo controlled, double blind, double dummy, multicenter trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine. ECSMOKE

Assistance Publique Hopitaux De Paris14 个研究点 分布在 1 个国家目标入组 650 人开始时间: 2024年10月31日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
650
试验地点
14
主要终点
Continuous smoking abstinence rate during the last 4 weeks of a treatment period of 3 months.

研究概览

简要总结

To assess the efficacy of electronic cigarettes containing nicotine (ECwN) comparatively to an EC without nicotine (ECwoN) and to a reference, licensed smoking cessation medication: varenicline.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Smokers smoking at least 10 cigarettes/day (factory made or roll-your-own) in the past year
  • Aged 18 to 70 years
  • Motivated to quit defined as a score > 5 on a visual rating scale ranging from 0 (not motivated at all) to 10 (extremely motivated)

排除标准

  • any unstable disease condition within the last 3 months defined by the investigator as major change in symptoms or treatments, such as : see protocol
  • any life threatening condition with life-expectancy of less than 3 months
  • alcohol use disorder defined as a score ? 10 on the AUDIT-C questionnaire
  • abuse of or dependence on illegal drugs in the last 6 months revealed by the medical history
  • regular use of tobacco products other than cigarettes
  • current or previous (last 6 months) use of electronic cigarette
  • pregnant women
  • breastfeeding women

结局指标

主要结局

Continuous smoking abstinence rate during the last 4 weeks of a treatment period of 3 months.

Continuous smoking abstinence rate during the last 4 weeks of a treatment period of 3 months.

次要结局

  • The assessment criterion of the safety will be the comparison of serious adverse events and non-serious adverse events
  • Point prevalence abstinence: self-report of 7-day smoking abstinence at each visit associated with expired air CO ≤ 8 ppm.
  • Time to relapse to smoking after the predefined target quit day
  • Change in cigarettes/day consumption
  • Change in craving for tobacco
  • Change in withdrawal symptoms

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Dr Ivan Berlin

Scientific

Assistance Publique Hopitaux De Paris

研究点 (14)

Loading locations...

相似试验